{"title":"Treatment of Staphylococcus aureus bacteremia and secondary infections","authors":"Allan G. Jensen MD","doi":"10.1016/S1069-417X(00)80039-4","DOIUrl":null,"url":null,"abstract":"<div><p><em>S. aureus</em> bacteremia is still a serious complication associated with a high mortality. The type of bacteremia is related to outcome and therefore, both the origin of infection and focus identification are highly important for treatment. In general, β-lactam antibiotics or, eventually, vancomycin are still the drugs of choice. The patient should be treated for 2 weeks in uncomplicated <em>S. aureus</em> bacteremia and longer in case of a secondary focus.</p></div>","PeriodicalId":100102,"journal":{"name":"Antimicrobics and Infectious Diseases Newsletter","volume":"18 10","pages":"Pages 73-75"},"PeriodicalIF":0.0000,"publicationDate":"2000-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1069-417X(00)80039-4","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Antimicrobics and Infectious Diseases Newsletter","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1069417X00800394","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
S. aureus bacteremia is still a serious complication associated with a high mortality. The type of bacteremia is related to outcome and therefore, both the origin of infection and focus identification are highly important for treatment. In general, β-lactam antibiotics or, eventually, vancomycin are still the drugs of choice. The patient should be treated for 2 weeks in uncomplicated S. aureus bacteremia and longer in case of a secondary focus.